{"id":1966,"date":"2025-03-03T11:28:02","date_gmt":"2025-03-03T10:28:02","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=1966"},"modified":"2025-03-10T09:18:54","modified_gmt":"2025-03-10T08:18:54","slug":"ascertain-releases-3-things-about-video-series","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/hr\/ascertain-releases-3-things-about-video-series\/","title":{"rendered":"ASCERTAIN releases &#8216;3 Things About&#8217; Video series"},"content":{"rendered":"\n<p>We are excited to announce the release of  the &#8216;3 Things About&#8217; series. With these six videos we aim to make complex issues more accessible, fostering a deeper understanding of the challenges and opportunities in topics around ASCERTAIN.<\/p>\n\n\n\n<p>In front of the camera are <a href=\"https:\/\/www.linkedin.com\/in\/carin-uyl-de-groot-746b93133\/\">Carin Uyl-de Groot<\/a> (project coordinator), Professor of Health Technology Assessment, and <a href=\"https:\/\/www.linkedin.com\/in\/fthielen\/\">Frederick Thielen<\/a>, Assistant Professor of Health Technology Assessment at the Erasmus University Rotterdam. Each of them explains three topics in the format &#8220;three things you might not know about\u2026&#8221;.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-overview-of-the-videos\">Overview of the Videos<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"558\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/market-access-1024x558.png\" alt=\"\" class=\"wp-image-1975\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/market-access-980x534.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/market-access-480x261.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<h3 class=\"wp-block-heading\" id=\"h-3-things-about-market-access\"><strong>3 Things About Market Access<\/strong><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=8NhuaohK_Qg\">Click here to watch.<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"558\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/tiered-pricing-1024x558.png\" alt=\"\" class=\"wp-image-1981\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/tiered-pricing-980x534.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/tiered-pricing-480x262.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\" id=\"h-3-things-about-tiered-pricing\"><strong>3 Things About Tiered Pricing<\/strong><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=OlmiWOpy6IA\">Click here to watch.<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"558\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/pricing-new-drugs-1024x558.png\" alt=\"\" class=\"wp-image-1982\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/pricing-new-drugs-980x534.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/pricing-new-drugs-480x262.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\" id=\"h-3-things-about-pricing-of-new-drugs\"><strong>3 Things About Pricing of New Drugs<\/strong><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls\">Click here to watch.<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"558\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/reimbursement-1024x558.png\" alt=\"\" class=\"wp-image-1983\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/reimbursement-980x534.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/reimbursement-480x262.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\" id=\"h-3-things-about-reimbursement\"><strong>3 Things About Reimbursement<\/strong><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=e36OtJA90Qg\">Click here to watch.<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"558\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/cost-effectivenes-1024x558.png\" alt=\"\" class=\"wp-image-1984\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/cost-effectivenes-980x534.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/cost-effectivenes-480x261.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\" id=\"h-3-things-about-cost-effectiveness\"><strong><strong>3 Things About Cost-Effectiveness<\/strong><\/strong><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=xMF2ddO9abM\">Click here to watch.<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"560\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/cancer-drugs-1024x560.png\" alt=\"\" class=\"wp-image-1985\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/cancer-drugs-980x536.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/01\/cancer-drugs-480x262.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\" id=\"h-3-things-about-value-of-new-cancer-drugs\"><strong><strong><strong>3 Things About Value of New Cancer Drugs<\/strong><\/strong><\/strong><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=JWVUuhTT8Fo\">Click here to watch.<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n<p>These videos play a key role in the project&#8217;s mission to raise awareness and foster dialogue on the affordability and accessibility of health innovations. The videos are now available here on the ASCERTAIN website and social media channels.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-and-don-t-miss-the-making-of-video\">And don&#8217;t miss the making-of video<\/h5>\n\n\n\n<p>The videos were filmed on November 28, 2024, at the Gegevens Erasmus Studio of Erasmus University Rotterdam. <\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"540\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/12\/making-of-2-1024x540.png\" alt=\"\" class=\"wp-image-1970\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/12\/making-of-2-980x517.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/12\/making-of-2-480x253.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/12\/making-of-1024x536.png\" alt=\"\" class=\"wp-image-1971\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/12\/making-of-980x513.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/12\/making-of-480x251.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=JjYDG7BDNDE\">Watch here.<\/a><\/p>\n\n\n\n<p>We invite you to watch, share, and join the conversation about how we can work together to make healthcare more equitable and effective.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Making complex healthcare challenges accessible \u2014 explore insights on pricing, reimbursement, market access, and more in this video series.<\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[14],"class_list":["post-1966","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-healthcare"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ASCERTAIN releases &#039;3 Things About&#039; Video series - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"Making complex healthcare challenges accessible\u2014explore insights on pricing, reimbursement, market access, and more in this video series.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCERTAIN releases &#039;3 Things About&#039; Video series\" \/>\n<meta property=\"og:description\" content=\"Making complex healthcare challenges accessible\u2014explore insights on pricing, reimbursement, market access, and more in this video series.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T10:28:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-10T08:18:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"ASCERTAIN releases &#8216;3 Things About&#8217; Video series\",\"datePublished\":\"2025-03-03T10:28:02+00:00\",\"dateModified\":\"2025-03-10T08:18:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/\"},\"wordCount\":230,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"healthcare\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"hr\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/\",\"name\":\"ASCERTAIN releases '3 Things About' Video series - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2025-03-03T10:28:02+00:00\",\"dateModified\":\"2025-03-10T08:18:54+00:00\",\"description\":\"Making complex healthcare challenges accessible\u2014explore insights on pricing, reimbursement, market access, and more in this video series.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-releases-3-things-about-video-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASCERTAIN releases &#8216;3 Things About&#8217; Video series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN releases '3 Things About' Video series - ASCERTAIN","description":"Making complex healthcare challenges accessible\u2014explore insights on pricing, reimbursement, market access, and more in this video series.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/","og_locale":"hr_HR","og_type":"article","og_title":"ASCERTAIN releases '3 Things About' Video series","og_description":"Making complex healthcare challenges accessible\u2014explore insights on pricing, reimbursement, market access, and more in this video series.","og_url":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/","og_site_name":"ASCERTAIN","article_published_time":"2025-03-03T10:28:02+00:00","article_modified_time":"2025-03-10T08:18:54+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Napisao\/la":"Lena Jessen","Procijenjeno vrijeme \u010ditanja":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"ASCERTAIN releases &#8216;3 Things About&#8217; Video series","datePublished":"2025-03-03T10:28:02+00:00","dateModified":"2025-03-10T08:18:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/"},"wordCount":230,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["healthcare"],"articleSection":["Allgemein"],"inLanguage":"hr"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/","url":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/","name":"ASCERTAIN releases '3 Things About' Video series - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2025-03-03T10:28:02+00:00","dateModified":"2025-03-10T08:18:54+00:00","description":"Making complex healthcare challenges accessible\u2014explore insights on pricing, reimbursement, market access, and more in this video series.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/ascertain-releases-3-things-about-video-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/"},{"@type":"ListItem","position":2,"name":"ASCERTAIN releases &#8216;3 Things About&#8217; Video series"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/comments?post=1966"}],"version-history":[{"count":10,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1966\/revisions"}],"predecessor-version":[{"id":2100,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1966\/revisions\/2100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media?parent=1966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/categories?post=1966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/tags?post=1966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}